EUCTR2004-004021-98-IT进行中（未招募）不适用
A single arm phase IV study to assess efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-fluorouracil/folinic acid regimens as first line treatment for patients with metastatic colorectal cancer.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ROCHE
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A single arm Phase IV study to assess efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-fluorouracil/folinic acid regimens as first line treatment for patients with metastatic colorectal cancer. - N/AMetastatic colorectal cancerMedDRA version: 7Level: PTClassification code 10009954EUCTR2004-004021-98-ESF. Hoffmann-La Roche Ltd.200
进行中（未招募）
不适用
A single arm Phase II study to assess efficacy and safety of bevacizumab in combination with the standard therapy (interferon alfa-2a and vinblastine) as first-line treatment for patients with metastatic renal cell cancer (Bevacizumab with standard therapy in RCC) - Bevacizumab with standard therapy in RCCMetastatic renal cell cancerEUCTR2005-006161-13-DERoche Pharma AG
尚未招募
Unknown
A SINGLE ARM CLINICAL STUDY TO EVALUATE EFFICACY OF AGNIKARMA WITH GUDA IN PAIN MANAGEMENT OF JANUSANDHI SHOOLA W.S.R OSTEOARTHRITISCTRI/2023/07/054667Sane Guruji Rugnalaya Hadapsar pune
尚未招募
2 期
A clinical study to evaluate effectiveness of karanjadi lepa in dadru with special referance to bahihparimarjan chikista siddhant (when locally applied)CTRI/2023/08/057030Sane Guruji Arogya Kendra
招募中
2 期
A Study Of Nishadi Taila In Treatment Of Nabhi paka In NewbornsCTRI/2023/03/050294Dr.Shital Patil